These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 27634512)
1. Vaccine trust and the limits of information. Larson HJ Science; 2016 Sep; 353(6305):1207-8. PubMed ID: 27634512 [No Abstract] [Full Text] [Related]
2. Addressing Ebola and other outbreaks: a communication checklist for global health leaders, policymakers, and practitioners. Goldberg AB; Ratzan SC; Jacobson KL; Parker RM J Health Commun; 2015; 20(2):121-2. PubMed ID: 25729894 [No Abstract] [Full Text] [Related]
3. When Are Vaccine Mandates Appropriate? Shachar C; Reiss DR AMA J Ethics; 2020 Jan; 22(1):E36-42. PubMed ID: 31958389 [TBL] [Abstract][Full Text] [Related]
4. Using the Ebola outbreak as an opportunity to educate on vaccine utility. Brown B J Bioeth Inq; 2014 Dec; 11(4):415-6. PubMed ID: 25421820 [No Abstract] [Full Text] [Related]
5. Health communications and community mobilization during an Ebola response: partnerships with community and faith-based organizations. Santibañez S; Siegel V; O'Sullivan M; Lacson R; Jorstad C Public Health Rep; 2015; 130(2):128-33. PubMed ID: 25729101 [No Abstract] [Full Text] [Related]
7. Risk communication of vaccines: challenges in the post-trust environment. Bouder F Curr Drug Saf; 2015; 10(1):9-15. PubMed ID: 25859669 [TBL] [Abstract][Full Text] [Related]
8. Interview. Ebola: 'Wow, that is really tough'. Aylward B; Roberts L Science; 2014 Sep; 345(6202):1229-30. PubMed ID: 25214583 [No Abstract] [Full Text] [Related]
9. Effective risk communication and contact tracing for Ebola virus disease prevention and control - Experiences from Port Harcourt, Nigeria. Maduka O; Maleghemi S; Komakech W; Nwaduito I; Green P; Ikpe A; Ywoga D; Onyekwere N Public Health; 2016 Jun; 135():140-3. PubMed ID: 26976486 [No Abstract] [Full Text] [Related]
10. Clinical trials of Ebola vaccine must continue despite fall in number of cases. Gulland A BMJ; 2015 Feb; 350():h944. PubMed ID: 25691506 [No Abstract] [Full Text] [Related]
11. Ebola in west Africa: gaining community trust and confidence. Lancet; 2014 Jun; 383(9933):1946. PubMed ID: 24910220 [No Abstract] [Full Text] [Related]
12. Ebola: time to act. Nature; 2014 Sep; 513(7517):143-4. PubMed ID: 25209760 [No Abstract] [Full Text] [Related]
13. Effectiveness of Ring Vaccination as Control Strategy for Ebola Virus Disease. Kucharski AJ; Eggo RM; Watson CH; Camacho A; Funk S; Edmunds WJ Emerg Infect Dis; 2016 Jan; 22(1):105-8. PubMed ID: 26691346 [TBL] [Abstract][Full Text] [Related]
15. Vaccine Refusal and Trust: The Trouble With Coercion and Education and Suggestions for a Cure. Bester JC J Bioeth Inq; 2015 Dec; 12(4):555-9. PubMed ID: 26626065 [TBL] [Abstract][Full Text] [Related]
16. How Ebola-vaccine success could reshape clinical-trial policy. Butler D; Callaway E; Check Hayden E Nature; 2015 Aug; 524(7563):13-4. PubMed ID: 26245556 [No Abstract] [Full Text] [Related]
17. Ebola: improving science-based communication and local journalism. Chalaud D; Aghan D; Otindo V; Bennett A; Baldet T Lancet; 2015 Nov; 386(10009):2139. PubMed ID: 26638957 [No Abstract] [Full Text] [Related]
18. Progress toward vaccines for cholera, dengue, malaria, and Ebola. Cunningham KC; Hayney MS J Am Pharm Assoc (2003); 2014; 54(6):654, 656-7. PubMed ID: 25379984 [No Abstract] [Full Text] [Related]
19. Absorbing the Lessons of WHO's Ebola Response. Laws J Occup Health Saf; 2015 Sep; 84(9):4. PubMed ID: 26495615 [No Abstract] [Full Text] [Related]
20. The evolution of Ebola virus disease outbreaks. Gałas A Folia Med Cracov; 2014; 54(3):27-32. PubMed ID: 25694092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]